{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:29:33Z","timestamp":1792790973525,"version":"4.5.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institutes of Health Oxford-Cambridge Scholars Program","award":["Graduate fellowship to MSS"],"award-info":[{"award-number":["Graduate fellowship to MSS"]}],"id":[{"id":"https:\/\/ror.org\/03thhsh17","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health Intramural Research Program of the National Center for Advancing Translational Sciences","id":[{"id":"https:\/\/ror.org\/04pw6fb54","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Salla Treatment and Research Foundation","award":["Grant to LP"],"award-info":[{"award-number":["Grant to LP"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["5R01NS128907-17 to RS"],"award-info":[{"award-number":["5R01NS128907-17 to RS"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institutes of Health Intramural Research Program of the National Human Genome Research Institute","award":["HG-000215"],"award-info":[{"award-number":["HG-000215"]}],"id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health Intramural Research Program of the National Human Genome Research Institute","award":["HG-000215"],"award-info":[{"award-number":["HG-000215"]}],"id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institutes of Health Intramural Research Program of the National Human Genome Research Institute","award":["HG-000215"],"award-info":[{"award-number":["HG-000215"]}],"id":[{"id":"https:\/\/ror.org\/00baak391","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Department of Pharmacology, University of Oxford","id":[{"id":"https:\/\/ror.org\/052gg0110","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Lysosomal free sialic acid storage disorder (FSASD) is a rare neurodegenerative disease caused by biallelic mutations in\n                    <jats:italic>SLC17A5<\/jats:italic>\n                    , encoding the lysosomal sialic acid exporter, SLC17A5 (sialin). While the involvement of oligodendroglia in FSASD pathogenesis is established, the roles of other neural cell types remain elusive. In this study, we utilized radial glial cells (iRGCs), immature and mature astrocytes (iIAs and iMAs, respectively), and cortical neurons (iCNs) differentiated from induced pluripotent stem cells (iPSCs) derived from two individuals with FSASD, alongside two independent healthy donors for comparison. We employed a multifaceted profiling approach, including the assessment of cellular glycosphingolipids (GSLs), transcriptomics focused on GSL metabolism genes, and 4-methylumbelliferone-based lysosomal enzyme activity measurements. Our findings revealed significant elevations in free sialic acid levels across all FSASD cell types, indicating that iPSCs and derived iRGCs, iIAs, iMAs and iCNs may be used to model FSASD in vitro. We observed significant alterations in the abundance of specific GSL species, predominantly in mature astrocytes, with fewer changes in other cell types. Transcriptomic analyses uncovered differential expression of genes involved in GSL catabolism, including those encoding glycohydrolases. Enzyme assays corroborated the transcriptomic findings, showing heightened glycohydrolase activities, particularly in mature astrocytes. Collectively, these data may help refine our understanding of neural cell phenotypes and potential contributors to selective vulnerability in FSASD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-12682-4","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T14:28:39Z","timestamp":1755095319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lysosomal free sialic acid storage disorder iPSC-derived neural cells display altered glycosphingolipid metabolism"],"prefix":"10.1038","volume":"15","author":[{"given":"Marya S.","family":"Sabir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vukasin M.","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmi","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaitali","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Ormanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Steet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Huizing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Tristan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Christine V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"issue":"2","key":"12682_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/archneur.1979.00500380058006","volume":"36","author":"P Aula","year":"1979","unstructured":"Aula, P. et al. \u201cSalla disease\u201d: A new lysosomal storage disorder. Arch Neurol 36(2), 88\u201394 (1979).","journal-title":"Arch Neurol"},{"issue":"1","key":"12682_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1212\/WNL.33.1.57","volume":"33","author":"M Renlund","year":"1983","unstructured":"Renlund, M. et al. Salla disease: A new lysosomal storage disorder with disturbed sialic acid metabolism. Neurology 33(1), 57\u201366 (1983).","journal-title":"Neurology"},{"issue":"4","key":"12682_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/70585","volume":"23","author":"FW Verheijen","year":"1999","unstructured":"Verheijen, F. W. et al. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases. Nat. Genet. 23(4), 462\u2013465 (1999).","journal-title":"Nat. Genet."},{"issue":"3","key":"12682_CR4","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj2680621","volume":"268","author":"HJ Blom","year":"1990","unstructured":"Blom, H. J. et al. Defective glucuronic acid transport from lysosomes of infantile free sialic acid storage disease fibroblasts. Biochem. J. 268(3), 621\u2013625 (1990).","journal-title":"Biochem. J."},{"issue":"25","key":"12682_CR5","doi-asserted-by":"publisher","first-page":"19316","DOI":"10.1074\/jbc.M110.130716","volume":"285","author":"P Courville","year":"2010","unstructured":"Courville, P., Quick, M. & Reimer, R. J. Structure-function studies of the SLC17 transporter sialin identify crucial residues and substrate-induced conformational changes. J. Biol. Chem. 285(25), 19316\u201319323 (2010).","journal-title":"J. Biol. Chem."},{"issue":"4","key":"12682_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1172\/JCI115136","volume":"87","author":"GM Mancini","year":"1991","unstructured":"Mancini, G. M. et al. Sialic acid storage diseases. A multiple lysosomal transport defect for acidic monosaccharides. J. Clin. Invest. 87(4), 1329\u201335 (1991).","journal-title":"J. Clin. Invest."},{"issue":"23","key":"12682_CR7","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.1038\/sj.emboj.7600464","volume":"23","author":"P Morin","year":"2004","unstructured":"Morin, P., Sagne, C. & Gasnier, B. Functional characterization of wild-type and mutant human sialin. EMBO J 23(23), 4560\u20134570 (2004).","journal-title":"EMBO J"},{"issue":"14","key":"12682_CR8","doi-asserted-by":"publisher","first-page":"11489","DOI":"10.1074\/jbc.M111.313056","volume":"287","author":"N Pietrancosta","year":"2012","unstructured":"Pietrancosta, N. et al. Successful prediction of substrate-binding pocket in SLC17 transporter sialin. J Biol Chem 287(14), 11489\u201311497 (2012).","journal-title":"J Biol Chem"},{"issue":"2","key":"12682_CR9","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s10545-008-0879-9","volume":"31","author":"C Sagne","year":"2008","unstructured":"Sagne, C. & Gasnier, B. Molecular physiology and pathophysiology of lysosomal membrane transporters. J Inherit Metab Dis 31(2), 258\u2013266 (2008).","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"12682_CR10","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1074\/jbc.M411295200","volume":"280","author":"CC Wreden","year":"2005","unstructured":"Wreden, C. C., Wlizla, M. & Reimer, R. J. Varied mechanisms underlie the free sialic acid storage disorders. J Biol Chem 280(2), 1408\u20131416 (2005).","journal-title":"J Biol Chem"},{"key":"12682_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.135896","volume":"755","author":"M Huizing","year":"2021","unstructured":"Huizing, M. et al. Free sialic acid storage disorder: Progress and promise. Neurosci Lett 755, 135896 (2021).","journal-title":"Neurosci Lett"},{"key":"12682_CR12","unstructured":"Adams, D., & Wasserstein, M. Free Sialic Acid Storage Disorders, in GeneReviews((R)), M.P. Adam, et al., Editors. 2020: Seattle (WA)."},{"issue":"3","key":"12682_CR13","first-page":"433","volume":"20","author":"P Sonninen","year":"1999","unstructured":"Sonninen, P. et al. Brain involvement in Salla disease. AJNR Am. J. Neuroradiol. 20(3), 433\u2013443 (1999).","journal-title":"AJNR Am. J. Neuroradiol."},{"issue":"2","key":"12682_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymgme.2004.03.001","volume":"82","author":"R Kleta","year":"2004","unstructured":"Kleta, R. et al. Clinical, biochemical, and molecular diagnosis of a free sialic acid storage disease patient of moderate severity. Mol. Genet. Metab. 82(2), 137\u2013143 (2004).","journal-title":"Mol. Genet. Metab."},{"issue":"87\u201391","key":"12682_CR15","first-page":"e2","volume":"74","author":"R Barmherzig","year":"2017","unstructured":"Barmherzig, R. et al. A new patient with intermediate severe salla disease with hypomyelination: A literature review for Salla disease. Pediatr. Neurol. 74(87\u201391), e2 (2017).","journal-title":"Pediatr. Neurol."},{"issue":"5","key":"12682_CR16","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1055\/s-2008-1073028","volume":"25","author":"L Haataja","year":"1994","unstructured":"Haataja, L. et al. Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder. Neuropediatrics 25(5), 238\u2013244 (1994).","journal-title":"Neuropediatrics"},{"issue":"10","key":"12682_CR17","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1177\/08830738050200100601","volume":"20","author":"RP Morse","year":"2005","unstructured":"Morse, R. P. et al. Novel form of intermediate salla disease: clinical and neuroimaging features. J. Child Neurol. 20(10), 814\u2013816 (2005).","journal-title":"J. Child Neurol."},{"key":"12682_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fncel.2019.00212","volume":"13","author":"CN Barber","year":"2019","unstructured":"Barber, C. N. & Raben, D. M. Lipid metabolism crosstalk in the brain: Glia and neurons. Front Cell Neurosci. 13, 212 (2019).","journal-title":"Front Cell Neurosci."},{"issue":"49","key":"12682_CR19","doi-asserted-by":"publisher","first-page":"15355","DOI":"10.1523\/JNEUROSCI.3005-09.2009","volume":"29","author":"LM Prolo","year":"2009","unstructured":"Prolo, L. M., Vogel, H. & Reimer, R. J. The lysosomal sialic acid transporter sialin is required for normal CNS myelination. J. Neurosci. 29(49), 15355\u201315365 (2009).","journal-title":"J. Neurosci."},{"issue":"1","key":"12682_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-018-0025-4","volume":"4","author":"FM Platt","year":"2018","unstructured":"Platt, F. M. et al. Lysosomal storage diseases. Nat. Rev. Dis. Primers 4(1), 27 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"12682_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-642-55557-2_3","volume":"32","author":"H Rosner","year":"2003","unstructured":"Rosner, H. Developmental expression and possible roles of gangliosides in brain development. Prog. Mol. Subcell Biol. 32, 49\u201373 (2003).","journal-title":"Prog. Mol. Subcell Biol."},{"key":"12682_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/978-1-4684-7844-0_46","volume":"125","author":"L Svennerholm","year":"1980","unstructured":"Svennerholm, L. Gangliosides and synaptic transmission. Adv. Exp. Med Biol 125, 533\u2013544 (1980).","journal-title":"Adv. Exp. Med Biol"},{"issue":"7","key":"12682_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/S0300-9084(01)01308-6","volume":"83","author":"AA Vyas","year":"2001","unstructured":"Vyas, A. A. & Schnaar, R. L. Brain gangliosides: functional ligands for myelin stability and the control of nerve regeneration. Biochimie 83(7), 677\u2013682 (2001).","journal-title":"Biochimie"},{"issue":"2","key":"12682_CR24","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1073\/pnas.93.2.814","volume":"93","author":"LJ Yang","year":"1996","unstructured":"Yang, L. J. et al. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. U S A 93(2), 814\u2013818 (1996).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"12682_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1432-1033.1983.tb07114.x","volume":"130","author":"M Renlund","year":"1983","unstructured":"Renlund, M. et al. Free N-acetylneuraminic acid in tissues in Salla disease and the enzymes involved in its metabolism. Eur. J. Biochem. 130(1), 39\u201345 (1983).","journal-title":"Eur. J. Biochem."},{"key":"12682_CR26","doi-asserted-by":"crossref","unstructured":"Fois, A., et al., Free sialic acid storage disease. A new Italian case. Eur. J. Pediatr. 146(2): p. 195\u20138 (1987).","DOI":"10.1007\/BF02343235"},{"issue":"2","key":"12682_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/BF00283373","volume":"71","author":"J Baumkotter","year":"1985","unstructured":"Baumkotter, J. et al. N-Acetylneuraminic acid storage disease. Hum. Genet. 71(2), 155\u2013159 (1985).","journal-title":"Hum. Genet."},{"issue":"2","key":"12682_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0387-7604(95)00142-5","volume":"18","author":"C Nakano","year":"1996","unstructured":"Nakano, C. et al. A Japanese case of infantile sialic acid storage disease. Brain Dev 18(2), 153\u2013156 (1996).","journal-title":"Brain Dev"},{"issue":"1\u20132","key":"12682_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0009-8981(95)06243-2","volume":"247","author":"M Pitto","year":"1996","unstructured":"Pitto, M. et al. Impairment of ganglioside metabolism in cultured fibroblasts from Salla patients. Clin Chim Acta 247(1\u20132), 143\u2013157 (1996).","journal-title":"Clin Chim Acta"},{"issue":"1","key":"12682_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1042\/bj2500261","volume":"250","author":"K Mendla","year":"1988","unstructured":"Mendla, K. et al. Defective lysosomal release of glycoprotein-derived sialic acid in fibroblasts from patients with sialic acid storage disease. Biochem J 250(1), 261\u2013267 (1988).","journal-title":"Biochem J"},{"issue":"36","key":"12682_CR31","doi-asserted-by":"publisher","first-page":"21738","DOI":"10.1074\/jbc.271.36.21738","volume":"271","author":"V Chigorno","year":"1996","unstructured":"Chigorno, V., Tettamanti, G. & Sonnino, S. Metabolic processing of gangliosides by normal and Salla human fibroblasts in culture. A study performed by administering radioactive GM3 ganglioside. J. Biol. Chem. 271(36), 21738\u201344 (1996).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"12682_CR32","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/0005-2760(73)90055-6","volume":"296","author":"G Tettamanti","year":"1973","unstructured":"Tettamanti, G. et al. A new procedure for the extraction, purification and fractionation of brain gangliosides. Biochim. Biophys. Acta 296(1), 160\u2013170 (1973).","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"12682_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10719-021-10023-x","volume":"39","author":"KL Wallom","year":"2022","unstructured":"Wallom, K. L. et al. Glycosphingolipid metabolism and its role in ageing and Parkinson\u2019s disease. Glycoconj J 39(1), 39\u201353 (2022).","journal-title":"Glycoconj J"},{"issue":"3","key":"12682_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/glycob\/cwad008","volume":"33","author":"S Okun","year":"2023","unstructured":"Okun, S., Peek, A. & Igdoura, S. A. Neuraminidase 4 (NEU4): New biological and physiological player. Glycobiology 33(3), 182\u2013187 (2023).","journal-title":"Glycobiology"},{"key":"12682_CR35","doi-asserted-by":"crossref","unstructured":"Jia, F., Howlader, M. A., & Cairo, C.W. Integrin-mediated cell migration is blocked by inhibitors of human neuraminidase. Biochim. Biophys. Acta, 2016. 1861(9 Pt A): p. 1170\u20131179.","DOI":"10.1016\/j.bbalip.2016.06.013"},{"issue":"Pt 1","key":"12682_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/BJ20050017","volume":"390","author":"K Yamaguchi","year":"2005","unstructured":"Yamaguchi, K. et al. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 390(Pt 1), 85\u201393 (2005).","journal-title":"Biochem J"},{"key":"12682_CR37","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gene.2003.08.005","volume":"321","author":"EM Comelli","year":"2003","unstructured":"Comelli, E. M. et al. Identification and expression of Neu4, a novel murine sialidase. Gene 321, 155\u2013161 (2003).","journal-title":"Gene"},{"issue":"7","key":"12682_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/glycob\/cws057","volume":"22","author":"T Miyagi","year":"2012","unstructured":"Miyagi, T. & Yamaguchi, K. Mammalian sialidases: Physiological and pathological roles in cellular functions. Glycobiology 22(7), 880\u2013896 (2012).","journal-title":"Glycobiology"},{"key":"12682_CR39","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0065-2318(10)64007-3","volume":"64","author":"E Monti","year":"2010","unstructured":"Monti, E. et al. Sialidases in vertebrates: A family of enzymes tailored for several cell functions. Adv Carbohydr Chem Biochem 64, 403\u2013479 (2010).","journal-title":"Adv Carbohydr Chem Biochem"},{"issue":"Pt A","key":"12682_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.expneurol.2017.09.012","volume":"299","author":"V Seyrantepe","year":"2018","unstructured":"Seyrantepe, V. et al. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. Exp Neurol 299(Pt A), 26\u201341 (2018).","journal-title":"Exp Neurol"},{"issue":"12","key":"12682_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlr.2023.100463","volume":"64","author":"ML Allende","year":"2023","unstructured":"Allende, M. L. et al. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis. J Lipid Res 64(12), 100463 (2023).","journal-title":"J Lipid Res"},{"issue":"5","key":"12682_CR42","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1042\/BST20220711","volume":"51","author":"FM Platt","year":"2023","unstructured":"Platt, F. M. The expanding boundaries of sphingolipid lysosomal storage diseases; insights from Niemann-Pick disease type C. Biochem. Soc. Trans 51(5), 1777\u20131787 (2023).","journal-title":"Biochem. Soc. Trans"},{"issue":"5","key":"12682_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/humu.20676","volume":"29","author":"KS Hruska","year":"2008","unstructured":"Hruska, K. S. et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat 29(5), 567\u2013583 (2008).","journal-title":"Hum Mutat"},{"issue":"6","key":"12682_CR44","first-page":"540","volume":"63","author":"JJ Pedersen","year":"2022","unstructured":"Pedersen, J. J. et al. beta-Galactosidase deficiency in the GLB1 spectrum of lysosomal storage disease can present with severe muscle weakness and atrophy. JIMD Rep 63(6), 540\u2013545 (2022).","journal-title":"JIMD Rep"},{"issue":"4","key":"12682_CR45","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","volume":"123","author":"A Ortiz","year":"2018","unstructured":"Ortiz, A. et al. Fabry disease revisited: Management and treatment recommendations for adult patients. Mol Genet Metab 123(4), 416\u2013427 (2018).","journal-title":"Mol Genet Metab"},{"issue":"36","key":"12682_CR46","doi-asserted-by":"publisher","first-page":"26052","DOI":"10.1074\/jbc.M113.463562","volume":"288","author":"CM Ridley","year":"2013","unstructured":"Ridley, C. M. et al. beta-Glucosidase 2 (GBA2) activity and imino sugar pharmacology. J Biol Chem 288(36), 26052\u201326066 (2013).","journal-title":"J Biol Chem"},{"issue":"3","key":"12682_CR47","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/zeb.2015.1152","volume":"13","author":"S Sultana","year":"2016","unstructured":"Sultana, S. et al. Characterization of the Zebrafish Homolog of beta-Glucosidase 2: A Target of the Drug Miglustat. Zebrafish 13(3), 177\u2013187 (2016).","journal-title":"Zebrafish"},{"key":"12682_CR48","doi-asserted-by":"crossref","unstructured":"Ryckman, A.E., I. Brockhausen, and J.S. Walia, Metabolism of Glycosphingolipids and Their Role in the Pathophysiology of Lysosomal Storage Disorders. Int. J. Mol. Sci., 2020. 21(18).","DOI":"10.3390\/ijms21186881"},{"issue":"8","key":"12682_CR49","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/j.cmet.2021.07.006","volume":"33","author":"G Bonvento","year":"2021","unstructured":"Bonvento, G. & Bolanos, J. P. Astrocyte-neuron metabolic cooperation shapes brain activity. Cell Metab. 33(8), 1546\u20131564 (2021).","journal-title":"Cell Metab."},{"key":"12682_CR50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.neuroscience.2014.05.061","volume":"275","author":"B Linnartz-Gerlach","year":"2014","unstructured":"Linnartz-Gerlach, B., Mathews, M. & Neumann, H. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins. Neuroscience 275, 113\u2013124 (2014).","journal-title":"Neuroscience"},{"issue":"2","key":"12682_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00033.2013","volume":"94","author":"RL Schnaar","year":"2014","unstructured":"Schnaar, R. L., Gerardy-Schahn, R. & Hildebrandt, H. Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration. Physiol. Rev. 94(2), 461\u2013518 (2014).","journal-title":"Physiol. Rev."},{"key":"12682_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione, S. et al. Gangliosides in the brain: Physiology. Pathophysiol. Therapeutic Appl. Front Neurosci. 14, 572965 (2020).","journal-title":"Pathophysiol. Therapeutic Appl. Front Neurosci."},{"issue":"1","key":"12682_CR53","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1600-065X.2012.01135.x","volume":"248","author":"L Mayo","year":"2012","unstructured":"Mayo, L., Quintana, F. J. & Weiner, H. L. The innate immune system in demyelinating disease. Immunol. Rev. 248(1), 170\u2013187 (2012).","journal-title":"Immunol. Rev."},{"issue":"2","key":"12682_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0896-6273(00)80781-3","volume":"23","author":"TG Bush","year":"1999","unstructured":"Bush, T. G. et al. Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scar-forming, reactive astrocytes in adult transgenic mice. Neuron 23(2), 297\u2013308 (1999).","journal-title":"Neuron"},{"issue":"Pt 10","key":"12682_CR55","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1093\/brain\/awl165","volume":"129","author":"DJ Myer","year":"2006","unstructured":"Myer, D. J. et al. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129(Pt 10), 2761\u20132772 (2006).","journal-title":"Brain"},{"issue":"1","key":"12682_CR56","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/glia.21088","volume":"59","author":"H Toft-Hansen","year":"2011","unstructured":"Toft-Hansen, H., Fuchtbauer, L. & Owens, T. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59(1), 166\u2013176 (2011).","journal-title":"Glia"},{"issue":"37","key":"12682_CR57","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1523\/JNEUROSCI.1514-09.2009","volume":"29","author":"RR Voskuhl","year":"2009","unstructured":"Voskuhl, R. R. et al. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29(37), 11511\u201311522 (2009).","journal-title":"J Neurosci"},{"key":"12682_CR58","volume":"21","author":"R Lawrence","year":"2019","unstructured":"Lawrence, R. et al. Characterization of glycan substrates accumulating in GM1 Gangliosidosis. Mol. Genet. Metab. Rep. 21, 100524 (2019).","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"2","key":"12682_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.2174\/1566523218666180404162622","volume":"18","author":"MB Cachon-Gonzalez","year":"2018","unstructured":"Cachon-Gonzalez, M. B., Zaccariotto, E. & Cox, T. M. Genetics and Therapies for GM2 Gangliosidosis. Curr. Gene. Ther. 18(2), 68\u201389 (2018).","journal-title":"Curr. Gene. Ther."},{"key":"12682_CR60","doi-asserted-by":"crossref","unstructured":"Olsen, A. S. B, & Faergeman, N. J. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol, 2017. 7(5).","DOI":"10.1098\/rsob.170069"},{"issue":"8","key":"12682_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2023.159334","volume":"1868","author":"A Aguilera-Romero","year":"2023","unstructured":"Aguilera-Romero, A. et al. Impact of sphingolipids on protein membrane trafficking. Biochim. Biophys. Acta. Mol. Cell. Biol. Lipids 1868(8), 159334 (2023).","journal-title":"Biochim. Biophys. Acta. Mol. Cell. Biol. Lipids"},{"issue":"5","key":"12682_CR62","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.sbi.2009.06.001","volume":"19","author":"PH Lopez","year":"2009","unstructured":"Lopez, P. H. & Schnaar, R. L. Gangliosides in cell recognition and membrane protein regulation. Curr. Opin. Struct. Biol. 19(5), 549\u2013557 (2009).","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"4","key":"12682_CR63","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","volume":"108","author":"M Linnerbauer","year":"2020","unstructured":"Linnerbauer, M., Wheeler, M. A. & Quintana, F. J. Astrocyte Crosstalk in CNS Inflammation. Neuron 108(4), 608\u2013622 (2020).","journal-title":"Neuron"},{"issue":"25","key":"12682_CR64","doi-asserted-by":"publisher","first-page":"10195","DOI":"10.1523\/JNEUROSCI.0822-13.2013","volume":"33","author":"K Sandhoff","year":"2013","unstructured":"Sandhoff, K. & Harzer, K. Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J. Neurosci. 33(25), 10195\u201310208 (2013).","journal-title":"J. Neurosci."},{"issue":"2","key":"12682_CR65","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1042\/bj2180625","volume":"218","author":"K Mendla","year":"1984","unstructured":"Mendla, K. & Cantz, M. Specificity studies on the oligosaccharide neuraminidase of human fibroblasts. Biochem. J. 218(2), 625\u2013628 (1984).","journal-title":"Biochem. J."},{"issue":"Pt 3","key":"12682_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3630417","volume":"363","author":"CS Pillay","year":"2002","unstructured":"Pillay, C. S., Elliott, E. & Dennison, C. Endolysosomal proteolysis and its regulation. Biochem. J. 363(Pt 3), 417\u2013429 (2002).","journal-title":"Biochem. J."},{"issue":"26","key":"12682_CR67","doi-asserted-by":"publisher","first-page":"15247","DOI":"10.1016\/S0021-9258(19)84817-2","volume":"264","author":"GM Mancini","year":"1989","unstructured":"Mancini, G. M. et al. Characterization of a proton-driven carrier for sialic acid in the lysosomal membrane. Evidence for a group-specific transport system for acidic monosaccharides. J. Biol. Chem. 264(26), 15247\u201354 (1989).","journal-title":"J. Biol. Chem."},{"key":"12682_CR68","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.expneurol.2014.10.010","volume":"263","author":"P Hadaczek","year":"2015","unstructured":"Hadaczek, P. et al. GDNF signaling implemented by GM1 ganglioside; failure in Parkinson\u2019s disease and GM1-deficient murine model. Exp. Neurol. 263, 177\u2013189 (2015).","journal-title":"Exp. Neurol."},{"key":"12682_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1749-6632.1998.tb09669.x","volume":"845","author":"RW Ledeen","year":"1998","unstructured":"Ledeen, R. W. et al. The role of GM1 and other gangliosides in neuronal differentiation. Overview and new finding. Ann. NY Acad. Sci. 845, 161\u201375 (1998).","journal-title":"Ann. NY Acad. Sci."},{"key":"12682_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0079-6123(08)61942-1","volume":"101","author":"G Wu","year":"1994","unstructured":"Wu, G. & Ledeen, R. W. Gangliosides as modulators of neuronal calcium. Prog. Brain Res. 101, 101\u2013112 (1994).","journal-title":"Prog. Brain Res."},{"issue":"4","key":"12682_CR71","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jnr.490270432","volume":"27","author":"SU Kim","year":"1990","unstructured":"Kim, S. U. Neurobiology of human oligodendrocytes in culture. J Neurosci. Res. 27(4), 712\u2013728 (1990).","journal-title":"J Neurosci. Res."},{"issue":"2","key":"12682_CR72","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1471-4159.1979.tb00351.x","volume":"32","author":"RK Yu","year":"1979","unstructured":"Yu, R. K. & Iqbal, K. Sialosylgalactosyl ceramide as a specific marker for human myelin and oligodendroglial perikarya: gangliosides of human myelin, oligodendroglia and neurons. J. Neurochem. 32(2), 293\u2013300 (1979).","journal-title":"J. Neurochem."},{"key":"12682_CR73","doi-asserted-by":"crossref","unstructured":"Fazzari, M., et al., GM1 Oligosaccharide efficacy in Parkinson\u2019s disease: Protection against MPTP. Biomedicines, 2023. 11(5).","DOI":"10.3390\/biomedicines11051305"},{"key":"12682_CR74","doi-asserted-by":"crossref","unstructured":"Yu, R. K., Nakatani, Y., & Yanagisawa, M. The role of glycosphingolipid metabolism in the developing brain. J Lipid Res, 2009. 50 Suppl (Suppl): p. S440\u20135.","DOI":"10.1194\/jlr.R800028-JLR200"},{"issue":"6","key":"12682_CR75","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1111\/j.1471-4159.2007.04910.x","volume":"103","author":"S Ngamukote","year":"2007","unstructured":"Ngamukote, S. et al. Developmental changes of glycosphingolipids and expression of glycogenes in mouse brains. J. Neurochem. 103(6), 2327\u20132341 (2007).","journal-title":"J. Neurochem."},{"issue":"6","key":"12682_CR76","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1111\/j.1471-4159.1988.tb02484.x","volume":"50","author":"RK Yu","year":"1988","unstructured":"Yu, R. K. et al. Developmental changes in ganglioside composition and synthesis in embryonic rat brain. J. Neurochem. 50(6), 1825\u20131829 (1988).","journal-title":"J. Neurochem."},{"issue":"4","key":"12682_CR77","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0165-3806(82)90193-6","volume":"256","author":"LN Irwin","year":"1982","unstructured":"Irwin, L. N. & Irwin, C. C. Development changes and regional variation in the ganglioside composition of the rat hippocampus. Brain Res. 256(4), 481\u2013485 (1982).","journal-title":"Brain Res."},{"issue":"1\u20132","key":"12682_CR78","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0006-8993(95)00923-E","volume":"700","author":"M Kotani","year":"1995","unstructured":"Kotani, M., Terashima, T. & Tai, T. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res 700(1\u20132), 40\u201358 (1995).","journal-title":"Brain Res"},{"issue":"2","key":"12682_CR79","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0005-2760(89)90175-6","volume":"1005","author":"L Svennerholm","year":"1989","unstructured":"Svennerholm, L. et al. Human brain gangliosides: developmental changes from early fetal stage to advanced age. Biochim. Biophys. Acta 1005(2), 109\u2013117 (1989).","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"12682_CR80","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0197-0186(92)90057-X","volume":"20","author":"I Kracun","year":"1992","unstructured":"Kracun, I. et al. Gangliosides in the human brain development and aging. Neurochem. Int. 20(3), 421\u2013431 (1992).","journal-title":"Neurochem. Int."},{"issue":"2","key":"12682_CR81","first-page":"S107","volume":"135","author":"MS Sabir","year":"2022","unstructured":"Sabir, M. S. et al. A novel experimental mouse model to investigate a free sialic acid storage disorder (Salla disease). Mol. Genet. Metab. 135(2), S107 (2022).","journal-title":"Mol. Genet. Metab."},{"key":"12682_CR82","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.expneurol.2017.02.009","volume":"291","author":"S Stroobants","year":"2017","unstructured":"Stroobants, S. et al. Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice. Exp. Neurol. 291, 106\u2013119 (2017).","journal-title":"Exp. Neurol."},{"key":"12682_CR83","volume":"42","author":"MS Sabir","year":"2025","unstructured":"Sabir, M. S. et al. Lack of significant ganglioside changes in Slc17a5 heterozygous mice: Relevance to FSASD and Parkinson\u2019s disease. Biochem. Biophys. Rep. 42, 101979 (2025).","journal-title":"Biochem. Biophys. Rep."},{"key":"12682_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2024.103600","volume":"81","author":"MS Sabir","year":"2024","unstructured":"Sabir, M. S. et al. Generation and characterization of two iPSC lines derived from subjects with Free Sialic Acid Storage Disorder (FSASD). Stem Cell Res. 81, 103600 (2024).","journal-title":"Stem Cell Res."},{"issue":"4","key":"12682_CR85","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s12015-016-9662-8","volume":"12","author":"BA Baghbaderani","year":"2016","unstructured":"Baghbaderani, B. A. et al. Detailed characterization of human induced pluripotent stem cells manufactured for therapeutic applications. Stem Cell Rev Rep 12(4), 394\u2013420 (2016).","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"12682_CR86","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.stemcr.2023.06.007","volume":"18","author":"VM Jovanovic","year":"2023","unstructured":"Jovanovic, V. M. et al. A defined roadmap of radial glia and astrocyte differentiation from human pluripotent stem cells. Stem Cell Rep. 18(8), 1701\u20131720 (2023).","journal-title":"Stem Cell Rep."},{"issue":"12","key":"12682_CR87","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.stemcr.2021.11.004","volume":"16","author":"CA Tristan","year":"2021","unstructured":"Tristan, C. A. et al. Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells. Stem Cell Rep. 16(12), 3076\u20133092 (2021).","journal-title":"Stem Cell Rep."},{"key":"12682_CR88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.accb.2018.09.001","volume":"75","author":"R Schauer","year":"2018","unstructured":"Schauer, R. & Kamerling, J. P. Exploration of the Sialic Acid World. Adv Carbohydr. Chem. Biochem. 75, 1\u2013213 (2018).","journal-title":"Adv Carbohydr. Chem. Biochem."},{"issue":"2","key":"12682_CR89","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","volume":"331","author":"DC Neville","year":"2004","unstructured":"Neville, D. C. et al. Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling. Anal. Biochem. 331(2), 275\u2013282 (2004).","journal-title":"Anal. Biochem."},{"key":"12682_CR90","doi-asserted-by":"crossref","unstructured":"Priestman, D.A., et al., Analysis of glycosphingolipids from cell lines. 2024: protocols.io.","DOI":"10.17504\/protocols.io.x54v9pn14g3e\/v1"},{"issue":"1","key":"12682_CR91","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","volume":"14","author":"M Huebecker","year":"2019","unstructured":"Huebecker, M. et al. Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease. Mol. Neurodegener 14(1), 40 (2019).","journal-title":"Mol. Neurodegener"},{"issue":"8","key":"12682_CR92","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37(8), 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"issue":"12","key":"12682_CR93","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15(12), 550 (2014).","journal-title":"Genome Biol."},{"key":"12682_CR94","unstructured":"Blighe, K., Rana, S., Lewis, M., EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. 2018."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12682-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T03:00:40Z","timestamp":1757386840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12682-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12682"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12682-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29708"}}